Karachun Rita A
- SEC CIK
- 0001601572
No open-market purchases or sales filed in the past year.
Current role at each company
- CHRS Coherus Oncology, Inc.Directoras of Jun 9, 2026
- MRK Merck & Co., Inc.Sr. VP Fince-Global Controlleras of May 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Karachun Rita A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRK Merck & Co., Inc.
Sr. VP Fince-Global Controller3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2023 (view filing) | May 4 | 1 day | Karachun Rita ASr. VP Fince-Global Controller | SSale | −15.9K | $117.53 | −$1.87M | −25.8%45.7K after | |
| Nov 1, 2022 (view filing) | Oct 28 | 4 days | Karachun Rita ASr. VP Fince-Global Controller | SSale | −32.0K | $100.34 | −$3.21M | −43.8%41.1K after | |
| Nov 4, 2021 (view filing) | Nov 3 | 1 day | Karachun Rita ASr. VP Fince-Global Controller | SSale | −25.0K | $88.45 | −$2.21M | −41.1%35.8K after |